Canada markets open in 9 hours 7 minutes
  • S&P/TSX

    20,164.96
    -23.47 (-0.12%)
     
  • S&P 500

    4,422.30
    +10.51 (+0.24%)
     
  • DOW

    35,144.31
    +82.76 (+0.24%)
     
  • CAD/USD

    0.7973
    +0.0001 (+0.01%)
     
  • CRUDE OIL

    72.19
    +0.28 (+0.39%)
     
  • BTC-CAD

    46,322.06
    -2,066.06 (-4.27%)
     
  • CMC Crypto 200

    874.18
    -41.31 (-4.51%)
     
  • GOLD FUTURES

    1,798.60
    -0.60 (-0.03%)
     
  • RUSSELL 2000

    2,216.92
    +7.27 (+0.33%)
     
  • 10-Yr Bond

    1.2760
    -0.0100 (-0.78%)
     
  • NASDAQ futures

    15,100.00
    -17.75 (-0.12%)
     
  • VOLATILITY

    17.58
    +0.38 (+2.21%)
     
  • FTSE

    7,025.43
    -2.15 (-0.03%)
     
  • NIKKEI 225

    27,979.78
    +146.49 (+0.53%)
     
  • CAD/EUR

    0.6750
    0.0000 (0.00%)
     

Salarius: Q1 Earnings Snapshot

·1 min read

HOUSTON (AP) _ Salarius Pharmaceuticals, Inc. (SLRX) on Wednesday reported a loss of $1.9 million in its first quarter.

On a per-share basis, the Houston-based company said it had a loss of 6 cents.

The biotech drug developer posted revenue of $1.3 million in the period.

The company's shares closed at $1.08. A year ago, they were trading at $1.75.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SLRX at https://www.zacks.com/ap/SLRX

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting